Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC

Summary

Octapharma announced plans to build a $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, South Carolina, expected to create 1,500 jobs and establish domestic production of its plasma-based therapies.